Chronic Spontaneous Urticaria: How to Measure It and the Need to Define Treatment Success

por Armstrong, April W., Soong, Weily, Bernstein, Jonathan A.
Publicado 2023

Health-Related Quality of Life and Productivity Among US Patients with Severe Asthma

por Soong, Weily, Chipps, Bradley E, O’Quinn, Sean, Trevor, Jennifer, Carr, Warner W, Belton, Laura, Trudo, Frank, Ambrose, Christopher S
Publicado 2021

Dupilumab-Treated Patients with Asthma in the Real World: The RAPID Global Registry

por Gall, Rebecca, Jain, Neal, Soong, Weily, Settipane, Russell A., Xia, Changming, Zhang, Yi, Haselkorn, Tmirah, Jacob-Nara, Juby A., Siddiqui, Shahid
Publicado 2023

Rapidity of Improvement in Signs/Symptoms of Moderate-to-Severe Atopic Dermatitis by Body Region with Abrocitinib in the Phase 3 JADE COMPARE Study

por Alexis, Andrew, de Bruin-Weller, Marjolein, Weidinger, Stephan, Soong, Weily, Barbarot, Sebastien, Ionita, Ileana, Zhang, Fan, Valdez, Hernan, Clibborn, Claire, Yin, Natalie
Publicado 2022

The CHRONICLE Study of US Adults with Subspecialist-Treated Severe Asthma: Objectives, Design, and Initial Results

por Ambrose, Christopher S, Chipps, Bradley E, Moore, Wendy C, Soong, Weily, Trevor, Jennifer, Ledford, Dennis K, Carr, Warner W, Lugogo, Njira, Trudo, Frank, Tran, Trung N, Panettieri, Reynold A
Publicado 2020

Ligelizumab improves angioedema, disease severity and quality-of-life in patients with chronic spontaneous urticaria()

por Metz, Martin, Bernstein, Jonathan A., Giménez-Arnau, Ana M., Hide, Michihiro, Maurer, Marcus, Sitz, Karl, Soong, Weily, Sussman, Gordon, Hua, Eva, Barve, Avantika, Barbier, Nathalie, Balp, Maria-Magdalena, Severin, Thomas
Publicado 2022

Predicting Clinical Remission of Chronic Urticaria Using Random Survival Forests: Machine Learning Applied to Real-World Data

por Pivneva, Irina, Balp, Maria-Magdalena, Geissbühler, Yvonne, Severin, Thomas, Smeets, Serge, Signorovitch, James, Royer, Jimmy, Liang, Yawen, Cornwall, Tom, Pan, Jutong, Danyliv, Andrii, McKenna, Sarah Jane, Marsland, Alexander M., Soong, Weily
Publicado 2022

Efficacy and Safety of Tralokinumab in Adolescents With Moderate to Severe Atopic Dermatitis: The Phase 3 ECZTRA 6 Randomized Clinical Trial

por Paller, Amy S., Flohr, Carsten, Cork, Michael, Bewley, Anthony, Blauvelt, Andrew, Hong, H. Chih-ho, Imafuku, Shinichi, Schuttelaar, Marie L. A., Simpson, Eric L., Soong, Weily, Arlert, Petra, Lophaven, Katja Wendicke, Kurbasic, Azra, Soldbro, Lise, Vest, Natacha Strange, Wollenberg, Andreas
Publicado 2023

Long-Term Efficacy and Safety of Dupilumab in Adolescents with Moderate-to-Severe Atopic Dermatitis: Results Through Week 52 from a Phase III Open-Label Extension Trial (LIBERTY AD...

por Blauvelt, Andrew, Guttman-Yassky, Emma, Paller, Amy S., Simpson, Eric L., Cork, Michael J., Weisman, Jamie, Browning, John, Soong, Weily, Sun, Xian, Chen, Zhen, Kosloski, Matthew P., Kamal, Mohamed A., Delevry, Dimittri, Chuang, Chien-Chia, O’Malley, John T., Bansal, Ashish
Publicado 2022

A randomized trial of the efficacy and safety of quilizumab in adults with inadequately controlled allergic asthma

por Harris, Jeffrey M., Maciuca, Romeo, Bradley, Mary S., Cabanski, Christopher R., Scheerens, Heleen, Lim, Jeremy, Cai, Fang, Kishnani, Mona, Liao, X. Charlene, Samineni, Divya, Zhu, Rui, Cochran, Colette, Soong, Weily, Diaz, Joseph D., Perin, Patrick, Tsukayama, Miguel, Dimov, Dimo, Agache, Ioana, Kelsen, Steven G.
Publicado 2016

Efficacy and Safety of Upadacitinib Treatment in Adolescents With Moderate-to-Severe Atopic Dermatitis: Analysis of the Measure Up 1, Measure Up 2, and AD Up Randomized Clinical Tr...

por Paller, Amy S., Ladizinski, Barry, Mendes-Bastos, Pedro, Siegfried, Elaine, Soong, Weily, Prajapati, Vimal H., Lio, Peter, Thyssen, Jacob P., Simpson, Eric L., Platt, Andrew M., Raymundo, Eliza M., Liu, Jianzhong, Calimlim, Brian M., Huang, Xiaohong, Gu, Yihua, Hu, Xiaofei, Yang, Yang, Su, John C., Zheng, Min, Yamamoto-Hanada, Kiwako, Teixeira, Henrique D., Irvine, Alan D.
Publicado 2023